Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-13-039793
Filing Date
2013-07-16
Accepted
2013-07-16 19:43:33
Documents
1
Period of Report
2013-07-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 v350141_form3.html 3  
1 FORM 3 v350141_form3.xml 3 2858
  Complete submission text file 0001144204-13-039793.txt   4185
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
RAYNOR DANIEL (Reporting) CIK: 0001068854 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31812 | Film No.: 13971325